Stratos Genomics Inc.
DNA expansion system using Xprobes and nanopore sequencing for next-generation DNA sequencing
- Sector
- Biotech
- Headquarters
- WA
- Founded
- 2008
- Latest Form D
- $20.2M, Jan 2018
- Total capital
- $39.2M
- Federal grants
- $829K
- 2 awards · 2011
- 2.0× sector median 1 award
- Private capital raised
- $38.3M
- 6 Form D · last Jan 2018
- 106 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 13
- 27 pending · first 2017
- Rank in peer group#131 of 1449
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 6th filing$20.2M
- Private capital raisedForm D · SEC · 5th filing$10M
- Private capital raisedForm D · SEC · 4th filing$2M
- Private capital raisedForm D · SEC · 3rd filing$2M
- Federal grantHealth and Human S · R21 · Sequencing by Expansion$419K
- Federal grantHealth and Human S · R21 · Sequencing by Expansion$410K
- Private capital raisedForm D · SEC · 2nd filing$211K
- Private capital raisedForm D · SEC · 1st filing$4M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1449 peers
Line = medianBiotech · Molecule
- Granted patents#131 · top 9%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Mark KokorisResearcherExecutive Officer, DirectorLinked by 1 patent · $829K in grants as PI
- Robert McRuerResearcherExecutive Officer, DirectorLinked by 1 patent
- Allan StephanExecutive Officer, DirectorNamed in SEC Form D filings
- Bob McRuerExecutive Officer, DirectorNamed in SEC Form D filings
- Harold KawaguchiDirectorNamed in SEC Form D filings
- Heiner DreismannDirectorNamed in SEC Form D filings
Show all 8 people
- Lee HuntsmanDirectorNamed in SEC Form D filings
- Stephen RoseDirectorNamed in SEC Form D filings
What it has protected
USPTO · 13 granted of 40- PendingDP04 Polymerase VariantsUSPTOApplication 19364573
- PendingDP04 Polymerase Variants With Improved AccuracyUSPTOApplication 19075134
- PendingDP04 Polymerase Variants With Improved AccuracyUSPTOApplication 18055966
Show all 40 patent records
- DP04 Polymerase VariantsAug 13, 2026 · Application 19364573Pending
- DP04 Polymerase Variants With Improved AccuracyJun 26, 2025 · Application 19075134Pending
- DP04 Polymerase Variants With Improved AccuracyOct 5, 2023 · Application 18055966Pending
- DP04 Polymerase VariantsJul 25, 2023 · US 11,708,566Granted
- DPO4 Polymerase Variants With Improved AccuracyDec 20, 2022 · US 11,530,392Granted
- DP04 Polymerase VariantsApr 12, 2022 · US 11,299,725Granted
- Translocation Control For Sensing By A NanoporeMay 20, 2021 · Application 16862300Pending
- Molecular Analysis System With Well ArrayMay 4, 2021 · US 10,996,213Granted
- Concentrating A Target Molecule For Sensing By A NanoporeDec 1, 2020 · US 10,851,405Granted
- Phosphoroamidate Esters, And Use And Synthesis ThereofSep 15, 2020 · US 10,774,105Granted
- DP04 Polymerase VariantsAug 18, 2020 · US 10,745,685Granted
- Translocation Control For Sensing By A NanoporeJun 9, 2020 · US 10,676,782Granted
- Translocation Control For Sensing By A NanoporeOct 29, 2019 · US 10,457,979Granted
- Phosphoroamidate Esters, And Use And Synthesis ThereofMay 28, 2019 · US 10,301,345Granted
- High Throughput Nucleic Acid Sequencing By ExpansionNov 22, 2018 · Application 15883431Pending
- High Throughput Nucleic Acid Sequencing By Expansion And Related MethodsMar 29, 2018 · Application 15691279Pending
- High Throughput Nucleic Acid Sequencing By ExpansionMar 20, 2018 · US 9,920,386Granted
- Polynucleotide Binding Protein SequencingFeb 15, 2018 · Application 15555438Pending
- High Throughput Nucleic Acid Sequencing By Expansion And Related MethodsSep 26, 2017 · US 9,771,614Granted
- Single Molecule Nucleic Acid Sequencing With Molecular Sensor ComplexesJun 8, 2017 · Application 15232593Pending
- Concentrating A Target Molecule For Sensing By A NanoporeJun 6, 2017 · US 9,670,526Granted
- Multiplexed Identification Of Nucleic Acid SequencesFeb 9, 2017 · Application 15235828Pending
- Multiplexed Identification Of Nucleic Acid SequencesMay 22, 2014 · Application 14065058Pending
- High Throughput Nucleic Acid Sequencing By ExpansionJul 4, 2013 · Application 13691085Pending
- Directed Evolution Of Enzymes By Plasmid Tagging In DropletsApplication PCTUS2017054021Pending
- Single Molecule Nucleic Acid Detection By Mismatch CleavageApplication 62541285Pending
- DP04 Polymerase VariantsApplication 62501526Pending
- Molecular Analysis System With Well ArrayApplication PCTUS2017013162Pending
- DP04 Polymerase VariantsApplication PCTUS2016061661Pending
- Directed Evolution Of Enzymes By Plasmid Tagging In DropletsApplication 62412693Pending
- Directed Evolution Of Enzymes By Plasmid Tagging In DropletsApplication 62401780Pending
- Single Molecule Nucleic Acid Sequencing With Molecular Sensor ComplexesApplication PCTUS2016046195Pending
- DP04 Polymerase VariantsApplication 62328967Pending
- Polynucleotide Binding Protein Sequencing Cross Reference To Related ApplicationsApplication PCTUS2016020752Pending
- Molecular Analysis System With Well ArrayApplication 62277873Pending
- Phosphoroamidate Esters, And Use And Synthesis ThereofApplication PCTUS2015061935Pending
- DP04 Polymerase VariantsApplication 62255918Pending
- Single Molecule Nucleic Acid Sequencing With Molecular Sensor ComplexesApplication 62203308Pending
- Translocation Control For Sensing By A NanoporeApplication PCTUS2015030797Pending
- Polynucleotide Binding Protein SequencingApplication 62127464Pending
Related companies, and why
- Boston Bioprocess, Inc.Similar federal contract value in Biotech · null in contracts
- Neo Quantum Era Inc.Similar federal contract value in Biotech · null in contracts
- NRX Pharmaceuticals, Inc.Similar federal contract value in Biotech · null in contracts
- ZY THERAPEUTICS INC.Similar federal contract value in Biotech · null in contracts
- Reprogram Biosciences, Inc.Similar federal contract value in Biotech · null in contracts
- Cynaptec Pharmaceuticals, Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .